Max Donley
Overview
Max Donley received an average of $2M in total compensation, including $334K in salary, at Aurinia Pharmaceuticals from 2019 to 2021. Max Donley also received an average of $1M at Sucampo Pharmaceuticals from 2014 to 2016.
- 2021
- 2020
- 2019
- 2016
- 2015
- 2014
Aurinia PharmaceuticalsEVP, Operations and Strategy
Aurinia PharmaceuticalsEVP, Operations and Strategy
Aurinia PharmaceuticalsEVP, Operations and Strategy
Sucampo PharmaceuticalsEVP, Global Human Resources, Information Technology and Strategy
Sucampo PharmaceuticalsEVP, Global Human Resources, Information Technology and Strategy
Sucampo PharmaceuticalsEVP, Global Human Resources, Information Technology and Strategy
Source: SEC filings on April 18, 2022, May 10, 2021, and April 21, 2017.
Related executives
We found ten more executives who work or worked at Aurinia Pharmaceuticals and Sucampo Pharmaceuticals.
Peter Greenleaf
Aurinia Pharmaceuticals
Chief Executive Officer
Stephen Robertson
Aurinia Pharmaceuticals
General Counsel
Joe Miller
Aurinia Pharmaceuticals
Chief Financial Officer
Max Colao
Aurinia Pharmaceuticals
Chief Commercial Officer
Dennis Bourgeault
Aurinia Pharmaceuticals
Chief Financial Officer
Peter Kiener
Sucampo Pharmaceuticals
Chief Scientific Officer
Matthias Alder
Sucampo Pharmaceuticals
General Counsel
Andrew Smith
Sucampo Pharmaceuticals